One of the world’s greatest challenges is understanding the nature of bacterial and viral infections and this was highlight by the COVID19 pandemic, says Woolcock Executive Director Professor Paul Foster. “Our climate, our environment, is changing. And with that, the behaviour of microbes will change. The nature of these pathogens is infection so we could potentially be more susceptible to infectious diseases as climate change occurs." Read more: https://lnkd.in/gJZv8Euh
Woolcock Institute of Medical Research
Research
Macquarie Park, New South Wales 3,270 followers
Leaders in breathing and sleep research
About us
The Woolcock Institute of Medical Research aims to improve respiratory and sleep health through excellence in research, clinical management and education. The Institute does this by providing a dynamic environment where over 200 medical researchers are uncovering the causes of disease, finding better treatments and translating these into practice. We are one of the world's leading respiratory and sleep research organisations. We apply a holistic approach to disease; from conducting fundamental research on the mechanisms of disease, to discovering new ways to prevent, treat and provide effective management. We are determined to translate the development of new and best practice treatments for sleep and breathing disorders into improved health for individual patients and the entire community. The Woolcock is committed to improving peoples lives through conducting and applying world-class medical research. This dedication to improve patient wellbeing is the focus of what we do.
- Website
-
http://www.woolcock.org.au
External link for Woolcock Institute of Medical Research
- Industry
- Research
- Company size
- 201-500 employees
- Headquarters
- Macquarie Park, New South Wales
- Type
- Nonprofit
- Specialties
- Respiratory disease, Sleep conditions, Lung cancer, and Medical clinic
Locations
-
Primary
2 Innovation Rd
Macquarie Park, New South Wales 2113, AU
Employees at Woolcock Institute of Medical Research
Updates
-
Interest in medicinal cannabis as a potential treatment for insomnia has been gaining momentum. In the US, the market for CBD products is booming with predictions it could reach $36 billion a year by 2033. But is there any proof that it works? Dr Camilla Hoyos talks about what we know scientifically about the effectiveness of cannabinoids as a treatment for insomnia and the difficulties posed to researching the area by legislative requirements. https://lnkd.in/g8MmPPGP
Is cannabis the answer to insomnia
woolcock.org.au
-
The Woolcock Institute hosted the Centre for Chronic Diseases of Ageing (CCDA) Research Showcase last week. We heard about the Centre’s cutting-edge research across areas such as brain stimulation to boost slow wave sleep, the potential neuroprotective qualities for insomnia medications, advances in drug to brain delivery, and the links between sleep disorders and brain waste clearance. Our special guest speaker was Professor Chris O’Neill on the epigenetics of chronic diseases. Special thanks to members of our wonderful consumer advisory panel who attended and participated in a discussion, adding their valuable input to our research. Their feedback will help guide our secondary analyses outcomes and discovery of future research projects that we can submit funding proposals for.
-
As part of their annual Day of Service program, McKinsey & Co consultants recently volunteered their time to facilitate a workshop with Woolcock leadership. We were thrilled to be chosen as a worthy charity and grateful for the amount of effort given by the McKinsey team #volunteer #givingback
-
Lung cancer is one of the respiratory research community’s greatest challenges and the Lung Cancer Research Network, based at the Woolcock Centre for Lung Cancer Research, is leading the way with collaborative projects and research into new treatments and diagnostics. “I want to build on the lung cancer programme at the Woolcock in partnership with other researchers and clinicians,” says Executive Director Professor Paul Foster. “This will form an important new partnership with Macquarie University and the Respiratory Health Service at Macquarie Hospital. “Lung cancer is a leading cause of cancer related deaths in Australia and is understudied. Our goal is to close the knowledge gap for improved health outcomes.” #LungCancerResearch
-
Our Executive Director, Professor Paul Foster, shares his thoughts on regional and rural services, asthma and mentorship: https://lnkd.in/g3BTUS6s #SleepResearch #AsthmaAdvances
-
The Woolcock’s Executive Director, Professor Paul Foster, is a world leader in the field of asthma research and has been instrumental in the development of biologics which, in the past 10 years, have provided answers for people with severe asthma. Read more: https://lnkd.in/gqbYuM55 #AsthmaResearch
-
The Woolcock's Executive Director, Professor Paul Foster, shares his thoughts on mentorship and why he's a scientist: https://lnkd.in/gfSca7vf #Mentorship #Science
-
We're #hiring a new Human Resources Manager in Macquarie Park, New South Wales. Apply today or share this post with your network.
-
Professor Paul Foster had a very informative visit to Professor Wei Chen’s laboratory at the School of Biomedical Engineering at The University of Sydney. Wei’s team does cutting-edge research into the development of wireless sensor systems for health monitoring. Many of Wei’s systems are applicable to monitoring sleep and cognitive function. Paul thanks Professor Chen for the invitation and looks forward to a visit at the Woolcock in 2025.